Viking Therapeutics, Inc. - Common Stock (VKTX)

CUSIP: 92686J106

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
113,177,462
Total 13F shares
45,087,675
Share change
-224,983
Total reported value
$374,231,879
Put/Call ratio
56%
Price per share
$8.30
Number of holders
150
Value change
-$7,341,449
Number of buys
72
Number of sells
62

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VKTX - Viking Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
STATE STREET CORP
13F
Company
6.4%
7,227,888
$71,845,000 31 Mar 2019
13F
ArrowMark Colorado Holdings LLC
13F
Company
4%
4,499,204
$44,722,000 31 Mar 2019
13F
BlackRock Finance, Inc.
13F
Company
3.6%
4,114,466
$40,896,000 31 Mar 2019
13F
VANGUARD GROUP INC
13F
Company
2.7%
3,109,641
$30,910,000 31 Mar 2019
13F
FMR LLC
13F
Company
2.7%
3,071,096
$30,527,000 31 Mar 2019
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
1.6%
1,757,000
$17,465,000 31 Mar 2019
13F
Park West Asset Management LLC
13F
Company
1.4%
1,572,507
$15,631,000 31 Mar 2019
13F
Fiera Capital Corp
13F
Company
1.3%
1,422,153
$14,136,000 31 Mar 2019
13F
CITADEL ADVISORS LLC
13F
Company
0.95%
1,073,574
$10,671,000 31 Mar 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.8%
900,014
$8,945,000 31 Mar 2019
13F
Sio Capital Management, LLC
13F
Company
0.75%
852,160
$8,470,000 31 Mar 2019
13F
Rubric Capital Management LP
13F
Company
0.72%
810,000
$8,051,000 31 Mar 2019
13F
NORTHERN TRUST CORP
13F
Company
0.67%
756,950
$7,524,000 31 Mar 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.59%
673,320
$6,692,000 31 Mar 2019
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.58%
654,300
$6,504,000 31 Mar 2019
13F
JENNISON ASSOCIATES LLC
13F
Company
0.45%
512,695
$5,096,000 31 Mar 2019
13F
Nicholas Investment Partners, LP
13F
Company
0.44%
494,730
$4,918,000 31 Mar 2019
13F
Opaleye Management Inc.
13F
Company
0.43%
485,000
$4,821,000 31 Mar 2019
13F
Rafferty Asset Management, LLC
13F
Company
0.39%
445,569
$4,429,000 31 Mar 2019
13F
Sculptor Capital LP
13F
Company
0.38%
435,600
$4,330,000 31 Mar 2019
13F
BAKER BROS. ADVISORS LP
13F
Company
0.38%
425,000
$4,225,000 31 Mar 2019
13F
MACQUARIE GROUP LTD
13F
Company
0.36%
402,306
$3,999,000 31 Mar 2019
13F
COLUMBUS CIRCLE INVESTORS
13F
Company
0.32%
358,777
$3,566,000 31 Mar 2019
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.29%
331,089
$3,291,000 31 Mar 2019
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.29%
329,726
$3,277,000 31 Mar 2019
13F
Bank of New York Mellon Corp
13F
Company
0.28%
319,960
$3,181,000 31 Mar 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.28%
313,101
$3,113,000 31 Mar 2019
13F
BAILARD, INC.
13F
Company
0.28%
312,200
$3,103,000 31 Mar 2019
13F
Russell Investments Group, Ltd.
13F
Company
0.28%
312,051
$3,087,000 31 Mar 2019
13F
UBS Group AG
13F
Company
0.24%
272,402
$2,708,000 31 Mar 2019
13F
Healthcare Value Capital, LLC
13F
Company
0.22%
250,000
$2,485,000 31 Mar 2019
13F
Cornerstone Capital, Inc.
13F
Company
0.22%
244,800
$2,433,000 31 Mar 2019
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.21%
237,466
$2,360,000 31 Mar 2019
13F
C WorldWide Group Holding A/S
13F
Company
0.21%
232,138
$2,307,000 31 Mar 2019
13F
David M. Knott
13F
Individual
0.19%
218,102
$2,168,000 31 Mar 2019
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.19%
212,048
$2,108,000 31 Mar 2019
13F
Allianz Asset Management GmbH
13F
Company
0.16%
180,799
$1,797,000 31 Mar 2019
13F
DAFNA Capital Management LLC
13F
Company
0.16%
179,200
$1,781,000 31 Mar 2019
13F
Endurant Capital Management LP
13F
Company
0.16%
178,448
$1,774,000 31 Mar 2019
13F
ALPS ADVISORS INC
13F
Company
0.15%
172,603
$1,716,000 31 Mar 2019
13F
DEUTSCHE BANK AG\
13F
Company
0.15%
171,757
$1,705,000 31 Mar 2019
13F
L & S Advisors Inc
13F
Company
0.15%
170,770
$1,698,000 31 Mar 2019
13F
Virtu Financial LLC
13F
Company
0.14%
163,782
$1,628,000 31 Mar 2019
13F
BLAIR WILLIAM & CO/IL
13F
Company
0.14%
163,283
$1,623,000 31 Mar 2019
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.14%
158,341
$1,574,000 31 Mar 2019
13F
TEACHERS ADVISORS, LLC
13F
Company
0.13%
152,076
$1,512,000 31 Mar 2019
13F
APIS CAPITAL ADVISORS, LLC
13F
Company
0.13%
150,000
$1,491,000 31 Mar 2019
13F
JANE STREET GROUP, LLC
13F
Company
0.13%
149,387
$1,485,000 31 Mar 2019
13F
LPL Financial LLC
13F
Company
0.13%
145,785
$1,449,000 31 Mar 2019
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.13%
145,198
$1,443,000 31 Mar 2019
13F

Institutional Holders of Viking Therapeutics, Inc. - Common Stock (VKTX) as of Q2 2019

As of 30 Jun 2019, Viking Therapeutics, Inc. - Common Stock (VKTX) was held by 150 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,087,675 shares. The largest 10 holders included STATE STREET CORP, ArrowMark Colorado Holdings LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Park West Asset Management LLC, Fiera Capital Corp, NORTHERN TRUST CORP, Sio Capital Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 150 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
158
Q2 2019 holders
150
Holder diff
-8
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.